Scinovex
articleTop 1% cited

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration

Ophthalmology · 2012 · Vol. 119(7) · pp. 1399–1411
Usha ChakravarthySimon HardingChris RogersSusan M. DownesAndrew LoterySarah WordsworthBarnaby C Reeves
Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Optic ConditionsMedicineMacular degenerationRanibizumabBevacizumabOphthalmologyChoroidal neovascularizationOptometrySurgeryChemotherapy

MeSH terms

BevacizumabRanibizumabAgedFemaleFluorescein AngiographyHumansMaleMiddle AgedQuality of LifeReadingVisual AcuityContrast SensitivityDrug CostsTreatment OutcomeCost of Illness
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.